A. David Paltiel

Professor of Public Health

Professor Paltiel aims to promote a reasoned approach to choices in the health sector. An expert in the field of pharmacoeconomics and disease modeling, he has published on the cost-effectiveness of a variety of medical technologies, pharmaceutical products, and public health activities. He has advised both industry and government on issues of health resource allocation and decision making. Professor Paltiel is the recipient of research grant support from the National Institute on Mental Health, the National Institute on Drug Abuse, and the National Institute of Allergy and Infectious Diseases.

Education

  • PhD, Yale University, 1992
  • MBA, Yale University, 1985
  • BA, McGill University, 1981

Publications

Selected Articles

The survival benefits of Antiretroviral Therapy in South Africa
M. D. April, R. Wood, B.K. Berkowitz, A.D. Paltiel, X. Anglaret, E. Losina, K.A. Freedberg and R.P. Walensky
Journal of Infectious Diseases
2014
A marginal benefit approach for vaccinating influenza ‘superspreaders’
K.J. Skene, A.D. Paltiel, E. Shim and A.P. Galvani
Medical Decision Making
2014
Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania
M.C. Fitzpatrick, K. Hampson, S. Cleaveland, I. Mzimbiri, F. Lankester, T. Lembo, L.A. Meyers, A.D. Paltiel, and A.P. Galvani
Annals of Internal Medicine
2014
Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty
L.G. Suter, A.D. Paltiel, B. N. Rome, D.H. Solomon, T.S. Thornhill, S.K. Abrams, J.N. Katz, E. Losina
PLoS ONE
2013
The Cost-Effectiveness of HIV Treatment as Prevention: Analysis of HPTN 052
R.P. Walensky, E.L. Ross,N. Kumarasamy, R. Wood, F. Noubary, A.D. Paltiel, Y.M. Nakamura, S.V. Godbole, et al.
New England Journal of Medicine
2013

Insights

Posts by A. David Paltiel

Achievements

Connecticut Academy of Science and Engineering
Elected as Member
2014
Institute of Medicine, Committee on Valuing Community-Based, Non-Clinical Prevention Policies and Wellness Strategies
2011
Scientific Advisory Committee, French National Agency for Research on AIDS (ANRS)
2009-2013
Institute of Medicine, Committee on Review of Priorities in the National Vaccine Plan
2008-2009
Institute of Medicine, Committee on Community Mitigation Strategies for Influenza Pandemic
2006-2007
Institute of Medicine, Committee on the President's Emergency Plan for AIDS Relief (PEPFAR)
2005-2007
Society for Medical Decision Making, Secretary-Treasurer and Executive Committee member
2006-
Institute of Medicine, Committee on the Ryan White CARE Act: Planning and Evaluation
2002-2004

Consultancies

  • Institute of Medicine
  • Brigham and Women’s Hospital
  • Massachusetts General Hospital
  • Weill Medical College of Cornell University